Stereotactic ablative body radiotherapy (SABR) for locally advanced exocrine pancreatic cancer
Topic Status Complete
Stereotactic ablative body radiotherapy (SABR) for locally advanced exocrine pancreatic cancer.
Summary
Health Technology Wales researchers searched for evidence on stereotactic ablative body radiotherapy (SABR) for locally advanced exocrine pancreatic cancer. HTW’s Assessment Group decided not to progress this topic further due to the development of commissioning arrangements by Welsh Health Specialised Services Committee.
Topic Exploration Report
TER426 11.2022
Access our guidance
Our advice documents are free to download, but we would be grateful if you could help us improve our services by telling us why you are looking at our advice and how you intend to use it.
